Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Reaktor Wins Significant Public Sector Procurement to Drive Finland’s Digitization
-
VelocityEHS Introduces VelocityAI
-
Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter
-
‘Supply Chains Under Pressure:’ WCC leads dialogue on innovation, resiliency and economic impact
-
Motivosity Named to the Inc. 5000 List of America’s Fastest-Growing Private Companies
-
Important Notice for Long-Term Shareholders of Flywire Corporation (NASDAQ: FLYW); iRobot Corporation (NASDAQ: IRBT); LuxUrban Hotels, Inc. (OTC: LUXH); and SelectQuote, Inc. (NYSE: SLQT): Grabar Law
-
AXIL Brands, Inc. Reports Strong Fiscal Year 2025 Financial Results
-
StepStone Private Wealth Solutions doubles AUM, exceeding $10 billion after adding $5 billion in under one year
-
Sienna Announces Completion of $175 Million Offering of 4.112% Series E Senior Unsecured Debentures
-
Red Cross 2025 wildfires response is largest domestic operation in recent history
-
Desjardins Reaches $2M Milestone in Support of Kids Help Phone and Youth Mental Health
-
Forget Productivity – Energy Is the Real KPI for Meetings, Says New Survey
-
Cube Biotech and X-Chem Partner to Enable DNA-encoded Library Screening of NativeMP™-stabilized Membrane Proteins
-
Freight Technologies Announces Second Quarter 2025 Results
-
Summit Nanotech Announces In-House Demonstration Plant in Santiago to Accelerate Commercial Lithium Projects
-
Beacon Therapeutics Announces EURETINA 2025 Presentations on 9+-Month Phase 2 DAWN and 36-Month Phase 2 SKYLINE Trial Data for laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP)
-
Enphase Energy Achieves Compliance for Europe’s New Cybersecurity Requirements on Wireless Devices
-
Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference
-
Maxus Mining Announces Appointment of Nathan Bridge as Technical Advisor
-
Akebia Therapeutics and Innovative Renal Care Announce Nationwide Availability of Vafseo® (vadadustat) Across All IRC Dialysis Clinics
-
Freshpet, Inc. to Participate in the Barclays 18th Annual Global Consumer Staples Conference
-
Syntec Optics (Nasdaq: OPTX) Assigns Decorated Veteran as Assistant Director, Strategic Military Sales & Customer Development
-
LendFriend Expands Crypto Mortgage Programs to California, Colorado, Florida, and Texas
-
Twin Disc Announces Full Year and Fourth Quarter Results
-
Vaidio Launches 9.1 Release, Accelerates Enterprise Vision AI with Next-Generation Features
-
Advent Technologies and Global Semiconductor & Wireless Technology Company Sign Agreement for Ion Pair Membrane Development for Gas Sensing
-
Asia Broadband Gold and Silver Production Upward Trend Continues In Second Quarter, As Its Ore Stockpile Processing Plant’s Second Phase Installation Advances Towards Completion
-
Valitor Announces Upcoming Presentations at the Ophthalmology Futures Retina Forum and Euretina Conference, Including New Data for its Long-Acting Anti-VEGF Drug Candidate for Wet AMD, VLTR-559
-
VeonGen Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for VG801 Gene Therapy for Stargardt Disease
-
Fabletics Deploys GreyOrange’s gStore to Transform In-Store Inventory Management
-
Rent the Runway Announces Growth Recapitalization and Strategy Expansion
-
Catheter Precision Announces the Start of Enrollment for the LockeT Compare Study
-
GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs: COYY, TSYY, NVYY, XBTY, TQQY and YSPY
-
NANO Nuclear Energy Advances to U.S. Army xTechSearch 9 Finals Pitch Event
-
Rezolve Ai to Participate in Citi’s 2025 Global TMT Conference
-
Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
-
Immuneering Announces $25 Million Private Placement
-
Early Season Results Reveal Shifts in How Consumers Are Shopping for Back-to-School Supplies This Year, Circana Reports
-
Amaero Secures A$50 Million to Accelerate Growth Initiatives
-
Synergy CHC Corp to Present at the 2025 Gateway Conference on September 4th
-
Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
-
FAVO Capital President Shaun Quin Joins Forbes Business Council
-
Bitcoin Depot Named One of America’s Greatest Companies 2025 by Newsweek
-
Mobiquity Technologies Expands CMOne Adoption with Two New Clients
-
Beta Bionics Announces Participation at Upcoming Investor Conferences
-
UroGen Pharma to Present at Upcoming Investor Conferences
-
Ingersoll Rand to Participate in Upcoming Investor Conference
-
Syntec Optics (Nasdaq: OPTX) Assigns Decorated Veteran as Assistant Director, Strategic Military Sales & Customer Development
-
CUSIP Request Volumes for New Corporate Securities Increase in July
-
Magnite and Acxiom Forge Direct Integration to Enhance Addressable-Based Buying and Maximize Working Media in Streaming
